Global Conjunctivitis Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Description
Global Conjunctivitis Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Summary
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Conjunctivitis is more commonly referred to as pink eye. The whites of the eyes appear pink or red when the conjunctiva (the transparent membrane which lines part of the eyeball) becomes inflamed or infected.
According to APO Research, The global Conjunctivitis market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Conjunctivitis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Conjunctivitis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Conjunctivitis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Conjunctivitis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Conjunctivitis include Novartis (CH), Santen Pharmaceutical (JP), Bausch & Lomb (US), Allergan (US), Sun Pharmaceutical (ID), Akorn (US), Freda (CN), Sinqi (CN) and Univision (CN), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Conjunctivitis, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Conjunctivitis, also provides the sales of main regions and countries. Of the upcoming market potential for Conjunctivitis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Conjunctivitis sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Conjunctivitis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Conjunctivitis sales, projected growth trends, production technology, application and end-user industry.
Conjunctivitis segment by Company
Novartis (CH)
Santen Pharmaceutical (JP)
Bausch & Lomb (US)
Allergan (US)
Sun Pharmaceutical (ID)
Akorn (US)
Freda (CN)
Sinqi (CN)
Univision (CN)
Conjunctivitis segment by Type
Antibiotic
Pills
Ointment
Conjunctivitis segment by End Use
r
Newborns
Children
Adults
Conjunctivitis segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Conjunctivitis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Conjunctivitis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Conjunctivitis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Conjunctivitis market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Conjunctivitis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Conjunctivitis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Conjunctivitis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Table of Contents
180 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Conjunctivitis Market Size, 2019 VS 2023 VS 2030
- 1.3 Global Conjunctivitis Market Size Estimates and Forecasts (2019-2030)
- 1.4 Global Conjunctivitis Sales Estimates and Forecasts (2019-2030)
- 1.5 Global Conjunctivitis Market Average Price (2019-2030)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 2 Global Conjunctivitis Market Dynamics
- 2.1 Conjunctivitis Industry Trends
- 2.2 Conjunctivitis Industry Drivers
- 2.3 Conjunctivitis Industry Opportunities and Challenges
- 2.4 Conjunctivitis Industry Restraints
- 3 Conjunctivitis Market by Manufacturers
- 3.1 Global Conjunctivitis Revenue by Manufacturers (2019-2024)
- 3.2 Global Conjunctivitis Sales by Manufacturers (2019-2024)
- 3.3 Global Conjunctivitis Average Sales Price by Manufacturers (2019-2024)
- 3.4 Global Conjunctivitis Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
- 3.5 Global Conjunctivitis Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Conjunctivitis Manufacturers, Product Type & Application
- 3.7 Global Conjunctivitis Manufacturers Commercialization Time
- 3.8 Market Competitive Analysis
- 3.8.1 Global Conjunctivitis Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Conjunctivitis Players Market Share by Revenue in 2023
- 3.8.3 2023 Conjunctivitis Tier 1, Tier 2, and Tier 3
- 4 Conjunctivitis Market by Type
- 4.1 Conjunctivitis Type Introduction
- 4.1.1 Antibiotic
- 4.1.2 Pills
- 4.1.3 Ointment
- 4.2 Global Conjunctivitis Sales by Type
- 4.2.1 Global Conjunctivitis Sales by Type (2019 VS 2023 VS 2030)
- 4.2.2 Global Conjunctivitis Sales by Type (2019-2030)
- 4.2.3 Global Conjunctivitis Sales Market Share by Type (2019-2030)
- 4.3 Global Conjunctivitis Revenue by Type
- 4.3.1 Global Conjunctivitis Revenue by Type (2019 VS 2023 VS 2030)
- 4.3.2 Global Conjunctivitis Revenue by Type (2019-2030)
- 4.3.3 Global Conjunctivitis Revenue Market Share by Type (2019-2030)
- 5 Conjunctivitis Market by Application
- 5.1 Conjunctivitis Application Introduction
- 5.1.1 Newborns
- 5.1.2 Children
- 5.1.3 Adults
- 5.2 Global Conjunctivitis Sales by Application
- 5.2.1 Global Conjunctivitis Sales by Application (2019 VS 2023 VS 2030)
- 5.2.2 Global Conjunctivitis Sales by Application (2019-2030)
- 5.2.3 Global Conjunctivitis Sales Market Share by Application (2019-2030)
- 5.3 Global Conjunctivitis Revenue by Application
- 5.3.1 Global Conjunctivitis Revenue by Application (2019 VS 2023 VS 2030)
- 5.3.2 Global Conjunctivitis Revenue by Application (2019-2030)
- 5.3.3 Global Conjunctivitis Revenue Market Share by Application (2019-2030)
- 6 Global Conjunctivitis Sales by Region
- 6.1 Global Conjunctivitis Sales by Region: 2019 VS 2023 VS 2030
- 6.2 Global Conjunctivitis Sales by Region (2019-2030)
- 6.2.1 Global Conjunctivitis Sales by Region (2019-2024)
- 6.2.2 Global Conjunctivitis Sales Forecasted by Region (2025-2030)
- 6.3 North America
- 6.3.1 North America Conjunctivitis Sales Growth Rate by Country: 2019 VS 2023 VS 2030
- 6.3.2 North America Conjunctivitis Sales by Country (2019-2030)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.4 Europe
- 6.4.1 Europe Conjunctivitis Sales Growth Rate by Country: 2019 VS 2023 VS 2030
- 6.4.2 Europe Conjunctivitis Sales by Country (2019-2030)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Conjunctivitis Sales Growth Rate by Country: 2019 VS 2023 VS 2030
- 6.5.2 Asia Pacific Conjunctivitis Sales by Country (2019-2030)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 LAMEA
- 6.6.1 LAMEA Conjunctivitis Sales Growth Rate by Country: 2019 VS 2023 VS 2030
- 6.6.2 LAMEA Conjunctivitis Sales by Country (2019-2030)
- 6.6.3 Mexico
- 6.6.4 Brazil
- 6.6.5 Turkey
- 6.6.6 GCC Countries
- 7 Global Conjunctivitis Revenue by Region
- 7.1 Global Conjunctivitis Revenue by Region
- 7.1.1 Global Conjunctivitis Revenue by Region: 2019 VS 2023 VS 2030
- 7.1.2 Global Conjunctivitis Revenue by Region (2019-2024)
- 7.1.3 Global Conjunctivitis Revenue by Region (2025-2030)
- 7.1.4 Global Conjunctivitis Revenue Market Share by Region (2019-2030)
- 7.2 North America
- 7.2.1 North America Conjunctivitis Revenue (2019-2030)
- 7.2.2 North America Conjunctivitis Revenue Share by Country: 2019 VS 2023 VS 2030
- 7.3 Europe
- 7.3.1 Europe Conjunctivitis Revenue (2019-2030)
- 7.3.2 Europe Conjunctivitis Revenue Share by Country: 2019 VS 2023 VS 2030
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Conjunctivitis Revenue (2019-2030)
- 7.4.2 Asia-Pacific Conjunctivitis Revenue Share by Country: 2019 VS 2023 VS 2030
- 7.5 LAMEA
- 7.5.1 LAMEA Conjunctivitis Revenue (2019-2030)
- 7.5.2 LAMEA Conjunctivitis Revenue Share by Country: 2019 VS 2023 VS 2030
- 8 Company Profiles
- 8.1 Novartis (CH)
- 8.1.1 Novartis (CH) Comapny Information
- 8.1.2 Novartis (CH) Business Overview
- 8.1.3 Novartis (CH) Conjunctivitis Sales, Price, Revenue and Gross Margin (2019-2024)
- 8.1.4 Novartis (CH) Conjunctivitis Product Portfolio
- 8.1.5 Novartis (CH) Recent Developments
- 8.2 Santen Pharmaceutical (JP)
- 8.2.1 Santen Pharmaceutical (JP) Comapny Information
- 8.2.2 Santen Pharmaceutical (JP) Business Overview
- 8.2.3 Santen Pharmaceutical (JP) Conjunctivitis Sales, Price, Revenue and Gross Margin (2019-2024)
- 8.2.4 Santen Pharmaceutical (JP) Conjunctivitis Product Portfolio
- 8.2.5 Santen Pharmaceutical (JP) Recent Developments
- 8.3 Bausch & Lomb (US)
- 8.3.1 Bausch & Lomb (US) Comapny Information
- 8.3.2 Bausch & Lomb (US) Business Overview
- 8.3.3 Bausch & Lomb (US) Conjunctivitis Sales, Price, Revenue and Gross Margin (2019-2024)
- 8.3.4 Bausch & Lomb (US) Conjunctivitis Product Portfolio
- 8.3.5 Bausch & Lomb (US) Recent Developments
- 8.4 Allergan (US)
- 8.4.1 Allergan (US) Comapny Information
- 8.4.2 Allergan (US) Business Overview
- 8.4.3 Allergan (US) Conjunctivitis Sales, Price, Revenue and Gross Margin (2019-2024)
- 8.4.4 Allergan (US) Conjunctivitis Product Portfolio
- 8.4.5 Allergan (US) Recent Developments
- 8.5 Sun Pharmaceutical (ID)
- 8.5.1 Sun Pharmaceutical (ID) Comapny Information
- 8.5.2 Sun Pharmaceutical (ID) Business Overview
- 8.5.3 Sun Pharmaceutical (ID) Conjunctivitis Sales, Price, Revenue and Gross Margin (2019-2024)
- 8.5.4 Sun Pharmaceutical (ID) Conjunctivitis Product Portfolio
- 8.5.5 Sun Pharmaceutical (ID) Recent Developments
- 8.6 Akorn (US)
- 8.6.1 Akorn (US) Comapny Information
- 8.6.2 Akorn (US) Business Overview
- 8.6.3 Akorn (US) Conjunctivitis Sales, Price, Revenue and Gross Margin (2019-2024)
- 8.6.4 Akorn (US) Conjunctivitis Product Portfolio
- 8.6.5 Akorn (US) Recent Developments
- 8.7 Freda (CN)
- 8.7.1 Freda (CN) Comapny Information
- 8.7.2 Freda (CN) Business Overview
- 8.7.3 Freda (CN) Conjunctivitis Sales, Price, Revenue and Gross Margin (2019-2024)
- 8.7.4 Freda (CN) Conjunctivitis Product Portfolio
- 8.7.5 Freda (CN) Recent Developments
- 8.8 Sinqi (CN)
- 8.8.1 Sinqi (CN) Comapny Information
- 8.8.2 Sinqi (CN) Business Overview
- 8.8.3 Sinqi (CN) Conjunctivitis Sales, Price, Revenue and Gross Margin (2019-2024)
- 8.8.4 Sinqi (CN) Conjunctivitis Product Portfolio
- 8.8.5 Sinqi (CN) Recent Developments
- 8.9 Univision (CN)
- 8.9.1 Univision (CN) Comapny Information
- 8.9.2 Univision (CN) Business Overview
- 8.9.3 Univision (CN) Conjunctivitis Sales, Price, Revenue and Gross Margin (2019-2024)
- 8.9.4 Univision (CN) Conjunctivitis Product Portfolio
- 8.9.5 Univision (CN) Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Conjunctivitis Value Chain Analysis
- 9.1.1 Conjunctivitis Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Conjunctivitis Production Mode & Process
- 9.2 Conjunctivitis Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Conjunctivitis Distributors
- 9.2.3 Conjunctivitis Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

